<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7953 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">444</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7953 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2 2.278 2.722 3 3.222 3.444 3.888 4.11 4.332 4.776 5.22 5.664 6.053 6.331 6.775 6.997 7.441 7.885 8.107 8.551 8.884 9.328 9.717 10.161 10.439 10.883 11.272 11.494 11.938 12.382 12.604 13.048 13.492 13.881 14.325 14.603 14.992 15.214 15.658 16.102 16.324 16.602 17.046 17.49 17.712 18.156 18.6" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Evitar la ingesta de azúcares de absorción rápida.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.278 2.722 3.389 3.833 4.277 4.721 5.165 5.443 5.665 6.109 6.442 6.886 7.275 7.719 7.997 8.441 8.83 9.052 9.441 9.885 10.552 10.996 11.218 11.662 11.884 12.328 12.717 12.939 13.328 13.55 13.939 14.383 14.827 15.105 15.327 15.771 16.215 16.659 17.103 17.492 17.714 18.103 18.547 18.936 19.214 19.658 20.102 20.491 20.713 21.157 21.379 21.823 22.212 22.434 22.878 23.322 23.544 23.766 23.988 24.432 24.71 25.154" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Recomendar azúcares complejos y cantidades sustanciales de ﬁ bra.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 723.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 723.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.8389 1.2829 1.7269 2.1159 2.3379 2.7819 3.2259 3.5039 3.9479 4.3369 4.5589 5.0029 5.4469 5.8909 6.2799 6.5018 6.9458 7.3348 7.7788 8.2228 8.6118 8.8338 9.2778 9.4998 9.9438 10.3328" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Consideraciones especiales:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 712.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.833 2.277 2.499 2.888 3.332 3.61 4.054 4.498 4.776 5.22 5.609 5.831 6.053 6.497 6.886 7.33 7.774 8.052 8.33 8.774 9.441 9.885 10.107 10.496 10.718 11.107 11.551 11.94 12.384 12.662 12.884 13.328 13.772" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Edulcorantes: aspartamo y sacarina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 701.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.112 2.556 3 3.444 3.666 3.888 4.11 4.554 4.998 5.22 5.664 6.108 6.552 6.996 7.218 7.496 7.94 8.607 9.051 9.329 9.718 10.162 10.384 10.828 11.05 11.439 11.883 12.327 12.771 12.993 13.215 13.604 14.048 14.492 14.714 15.158 15.38 15.602 16.046 16.435 16.713 17.157 17.824 18.268 18.712 19.156 19.378 19.767 20.211 20.6 20.822 21.266 21.488 21.932 22.376 22.654 23.098 23.32 23.764 24.153 24.375 24.653 25.097 25.375 25.597 26.041 26.485 26.707 27.151 27.595 27.984 28.206 28.65 28.872 29.316 29.538 29.982 30.26 30.704 31.093 31.371 31.815 32.037 32.481 32.703 33.147 33.591 34.035 34.257 34.701 35.09 35.534 36.201 36.423 36.867 37.311 37.589 38.033" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Alcohol: no debe tomarse alcohol con el estómago vacío para evitar un posible efecto hipoglucemiante.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 690.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.167 2.445 2.889 3.278 3.667 4.111 4.5 4.722 4.944 5.388 5.832 6.11 6.777 6.999 7.277 7.499 7.943 8.387 8.609 9.053 9.275 9.497 9.941 10.33 10.774 10.996 11.44 11.884 12.106 12.55 12.994 13.438 13.66 14.104 14.548 14.937 15.159 15.603 15.992 16.436 16.658 17.102 17.38 17.602 17.991 18.435 18.824" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Refrescos: permitido el uso de bebidas acalóricas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 679.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.111 2.333 2.555 2.944 3.388 3.61 3.888 4.332 4.721 5.165 5.832 6.276 6.72 7.164 7.608 7.886 8.33 8.552 8.941 9.385 9.607 9.885 10.329 10.718 10.996 11.274 11.496 11.885 12.274 12.496 12.94 13.384 13.606 13.995 14.439 15.106 15.55 15.772 16.439 16.883 17.327 17.549 17.993 18.437 18.659 19.103 19.381 19.825 20.214 20.658 21.102 21.38 21.602 21.991 22.435 22.657 23.101 23.545 23.823 24.267 24.489 24.711 25.155 25.377 25.933 26.327 26.883" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Sal: se recomendará su restricción como medida preventiva para la HTA.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 657.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.5 0.778 1.278 1.611 2.111 2.389 2.889 3.167 3.667 3.889 4.167 4.445 4.889 5.167 5.667" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Ejercicio físico</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 635.8375) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.506 2.173 2.395 2.839 3.283 3.672 4.116 4.338 4.56 5.004 5.226 5.67 5.892 6.336 6.725 7.169 7.836 8.058 8.502 8.724 9.113 9.335 9.779 10.223 10.89 11.334 11.778 12.056 12.5 12.722 12.944 13.388 13.61 13.999 14.443 14.887 15.276 15.498 15.942 16.164 16.386 16.608 17.052 17.496 17.94 18.162 18.606 18.828 19.05 19.494 19.716 19.938 20.382 20.771 21.215 21.437 21.659 22.103 22.547" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Disminuye la glucemia y aumenta la sensibilidad a la insulina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.783 2.227 2.616 3.06 3.727 3.949 4.393 4.837 5.281 5.725 5.947 6.169 6.613 6.835 7.113 7.557 8.001 8.223 8.445 8.778 9.222 9.611 9.833 10.277 10.721 10.943 11.387 11.831 12.053 12.497 12.719 13.163 13.441 13.83 14.052 14.441 14.663 15.107 15.329 15.773 16.217 16.495 16.939 17.383 17.605 17.994 18.438 18.66 18.882 19.326 19.77 19.992 20.381 20.825 21.103 21.547 21.936 22.214 22.658 22.936 23.158 23.547 23.991 24.435 24.824 25.268 25.49 25.712 26.156 26.6 26.822 27.1 27.544 27.822 28.489 28.933 29.155 29.544 29.988 30.432 30.71 30.932 31.376 31.82 32.264 32.708 33.152" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Se recomienda la realización de ejercicio aeróbico, de carácter suave, de forma continuada.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 2.116 2.338 2.782 3.226 3.67 3.892 4.336 4.614 5.058 5.447 5.725 5.947 6.336 6.78 7.058 7.28 7.724 7.946 8.39 8.668 9.112 9.334 9.723 10.167 10.556 11 11.389 11.611 12.055 12.277 12.499 12.943 13.165 13.554 13.998 14.665 15.109 15.553 15.997 16.219 16.608 16.83 17.274 17.718 17.996 18.44 18.884 19.162 19.606 19.828 20.272 20.716 20.994 21.438 21.882 22.104 22.771 22.993 23.437 23.659 24.103 24.325 24.547 24.991 25.213 25.657 25.879" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Conviene practicarlo 3-4 veces a la semana y durante 30-45 min al día. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.728 1.95 2.394 2.838 3.282 3.504 3.948 4.392 4.67 5.114 5.392 6.059 6.281 6.725 7.169 7.447 7.669 8.113 8.335 8.557 9.001 9.223 9.612 10.056 10.278 10.5 10.944 11.388 11.61 12.054 12.276 12.72 13.109 13.553 14.22 14.442 14.886 15.108 15.552 15.996 16.274 16.718 17.107 17.329 17.773 18.217 18.439 18.883 19.327 19.716 20.16 20.438 20.66 21.104 21.326 21.548 21.992 22.214 22.658 22.936 23.325 23.547 23.936 24.158 24.602 24.824 25.268 25.712 25.99 26.434 26.656 27.1 27.489 27.711 27.989 28.433 28.711 28.933 29.377 29.599 30.043 30.487 30.931 31.153 31.597 31.986 32.43 33.097 33.319 33.763 34.152 34.374" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Hay que determinar el nivel de glucemia antes de hacer el ejercicio para evitar hipoglucemias. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.95 1.394 1.616 2.06 2.504 2.893 3.337 3.615 3.837 4.226 4.67 4.892 5.336 5.725 5.947 6.391 6.613 6.891 7.113 7.557 7.779 8.001 8.445 8.667 9.111 9.389 9.778 10 10.389 10.611 11.055 11.277 11.666 12.11 12.554 12.776 13.22 13.442 13.664 14.331 14.775 15.164 15.386 16.053 16.497 16.719 17.163 17.385 17.774 18.218 18.44 18.662 19.106 19.495 19.939 20.161 20.383 20.827 21.049 21.438 21.882" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> No hacer coincidir el ejercicio con el máximo pico insulínico.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 569.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.833 1.333 1.833 2.111 2.611 3.111 3.611 3.889 4.389 4.889" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Medicación </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 547.8015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.389 1.611 2.111 2.333 2.833 3.333 3.833 4.111 4.333 4.833 5.333 5.777 5.999 6.499 6.832 7.332 7.554 8.054" font-family="g_d0_f6" font-size="1px" fill="rgb(64,198,192)">Antidiabéticos orales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 525.837) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 525.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.561 1.783 2.061 2.505 2.783 3.45 3.894 4.283 4.727 5.116 5.338 5.782 6.06 6.504 6.726 7.17 7.559 7.781 8.17 8.614 9.058 9.28 9.724 10.168 10.39 10.834 11.112 11.334 11.556 11.778 12.222 12.666 13.11 13.332 13.776 14.22 14.498 14.942 15.164 15.608 15.83 16.052 16.33 16.608 17.052 17.33 17.774 18.441 18.663 19.107 19.551 19.829 20.273 20.495 20.939 21.383 21.605 21.827 22.271 22.493 22.937 23.159 23.603 24.047 24.491 24.769 25.213 25.602 25.824 26.102 26.324 26.768 27.212 27.434 27.878 28.1" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Los fármacos orales son de utilidad para el tratamiento de la diabetes tipo 2. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 514.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 514.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.449 1.671 2.115 2.337 2.781 3.17 3.448 3.892 4.336 4.558 4.78 5.224 5.668 6.112 6.334 6.723 7.167 7.389 7.833 8.055 8.444 8.888 9.332 9.776 10.22 10.442 10.886 11.33 11.552 11.941 12.163 12.607 12.996 13.44 13.662 14.106 14.384 14.828 15.272 15.716 16.105 16.327 16.771 17.215 17.437 17.881 18.325 18.603 18.825 19.269 19.491 19.935 20.379 20.823 21.101 21.323 21.712 22.156 22.545 22.767 23.211 23.489 23.933 24.155 24.599 24.988 25.21 25.432 25.988 26.544 27.1 27.322" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> En la actualidad se dispone de cinco grupos de antidiabéticos orales (ADO):</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 503.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2.056 2.278 2.945 3.389 3.611 4.055 4.499 4.721 4.943 5.387 5.609 5.998 6.442 6.831 7.109 7.553 7.942 8.164 8.608 9.052 9.274 9.718 10.162 10.384 10.606 11.05 11.439 11.883 12.105 12.327 12.771 13.215 13.437 13.659 14.048 14.492 14.714 14.992 15.436 15.88 16.102 16.324 16.768 17.046 17.49 17.934 18.323 18.545 18.934 19.156 19.6 19.822 20.044 20.488 20.71 21.154 21.598 21.987 22.209 22.431 22.82 23.264 23.653 23.931 24.375 24.653 25.097 25.541 25.985 26.429 26.873 27.262 27.484 27.928 28.372 28.594 29.038 29.427 29.816 30.038 30.482 30.926 31.148 31.426 31.87 32.314 32.536 32.98 33.424 33.646" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Estimulan la secreción de insulina: sulfonilureas y glinidas (secretagogos de acción rápida).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 492.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.112 2.779 3.001 3.445 3.889 4.278 4.722 5.166 5.388 5.61 6.054 6.276 6.554 6.998 7.387 7.609 7.998 8.276 8.72 9.164 9.553 9.775 10.219 10.441 10.885 11.107 11.329 11.773 11.995 12.217 12.661 13.05 13.494 13.716 13.938 14.382 14.826 15.048 15.27 15.714 15.936 16.38 16.824 17.268 17.712 17.934 18.378 18.822 19.211 19.433 19.822 20.044 20.488 20.71 20.932 21.21 21.654 21.987 22.431 22.875 23.319 23.708" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Disminuyen la resistencia a la insulina: biguanidas y glitazonas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 481.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.777 3.166 3.61 4.054 4.276 4.72 4.942 5.386 5.83 6.052 6.496 6.94 7.218 7.662 8.051 8.495 8.939 9.161 9.383 9.827 10.049 10.493 10.937 11.326 11.77 12.048 12.437 12.659 13.103 13.547 13.769 14.213 14.657 14.879 15.323 15.545 15.989 16.378 16.822 17.211 17.655 17.877 18.099 18.321 18.765 19.209 19.431 19.875 20.097 20.541 20.985 21.263 21.707 22.096 22.318 22.762 23.206 23.428 23.65 24.094 24.483 24.705 25.149 25.371 25.649 26.093 26.315 26.759 26.981 27.425 27.814 28.258 28.647 28.869 29.313 29.757 30.146 30.59 30.979" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Reducen o enlentecen la absorción de glucosa: inhibidores de las alfa glucosidasas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.783 2.227 2.671 2.893 3.115 3.559 3.837 4.281 4.725 5.114 5.336 5.558 6.002 6.224 6.446 7.113 7.557 7.835 8.057 8.501 8.723 9.167 9.611 9.833 10.055 10.499 10.721 10.943 11.387 11.609 11.942 12.164 12.608 13.052 13.274 13.496 13.94 14.162 14.384 14.828 15.272 15.494 15.938 16.382 16.826 17.27 17.492 17.714 18.158 18.38 18.602 18.991 19.213 19.657 20.046 20.268 20.712 21.156 21.378 21.6 21.822 22.1 22.544 22.822 23.489 23.933 24.322 24.766 24.988 25.432 25.876 26.098 26.542 26.764 27.208 27.597 27.986 28.208 28.652 29.096 29.318 29.762 30.206 30.428 30.872 31.094 31.316 31.76 32.204 32.593 32.815 33.259 33.703 33.981 34.425 34.647 35.036 35.48 35.924 36.146 36.59 36.812 37.256 37.7 38.144 38.422 38.866 39.255 39.477 39.755 39.977 40.421 40.865 41.087 41.531 41.753 42.197 42.641 42.863 43.307 43.751 44.195" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Sulfonilureas (glimeripida, glipizida, gliquidona, gliclacida): fármaco de elección en el paciente con diabetes tipo 2 no obes</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 463.386592 459.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">o.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 448.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.444 3.833 4.277 4.666 5.11 5.554 5.998 6.442 6.72 6.942 7.386 7.608 7.83 8.274 8.718 9.385 9.829 10.273 10.551 10.995 11.217 11.661 12.105 12.327 12.771 13.215 13.604 14.048 14.27" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efecto secundario: aumento de peso. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 437.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.111 2.555 2.999 3.666 3.888 4.332 4.554 4.943 5.221 5.499 5.943 6.221 6.665 6.887 7.165 7.443 7.887 8.109 8.553 8.831 9.275 9.497 10.164 10.386 10.83 11.274 11.552 11.996 12.385 12.607 13.051 13.495 13.773 14.217 14.606 14.828 15.272 15.716 15.938 16.16 16.604 16.826 17.048 17.492 17.936 18.38 18.769 19.047 19.491" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Se administrará treinta minutos antes de la ingesta.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 415.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 415.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.061 1.505 1.949 2.393 2.837 3.059 3.503 3.947 4.336 4.558 4.78 5.447 5.891 6.169 6.447 6.891 7.169 7.836 8.058 8.502 8.946 9.168 9.39 9.612 9.89 10.334 10.612 11.279 11.723 12.112 12.556 12.778 13.222 13.666 13.888 14.332 14.554 14.998 15.387 15.776 15.998 16.442 16.886 17.108 17.552 17.996 18.274 18.718 18.94 19.384 19.828 20.272 20.661 21.105 21.494 21.716 22.16 22.382 22.826 23.048 23.437 23.659 23.881 24.325 24.769 25.436 25.658 26.047 26.491 26.88 27.102 27.491 27.935 28.379 28.601 29.045 29.267 29.711 30.155 30.599 30.877 31.321 31.71 31.932 32.21 32.432 32.876 33.32 33.542 33.986 34.208" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Biguanidas (metformina): fármaco de elección para obesos o dislipémicos con diabetes tipo 2. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 404.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.444 3.833 4.277 4.666 5.11 5.554 5.998 6.442 6.72 6.942 7.386 7.608 7.83 8.274 8.496 8.94 9.218 9.496 9.94 10.384 10.606 11.05 11.494 11.883 12.105 12.494 12.772 13.216 13.66 14.104 14.548 14.992 15.436 15.658 16.102 16.546 16.824 17.268" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efecto secundario: diarrea dosis-dependiente.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 393.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.556 2 2.444 2.833 3.277 3.499 3.888 4.332 4.776 5.165 5.609 5.831 6.275 6.497 6.941 7.385 7.829 8.051 8.495 8.884 9.328 9.995 10.217 10.661 10.883 11.327 11.771 11.993 12.66 13.104 13.548 13.992 14.27 14.714 14.992 15.436 15.88 16.102 16.546" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Nunca causa hipoglucemia en monoterapia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.339 1.783 2.005 2.449 2.893 3.282 3.504 3.726 4.004 4.448 4.892 5.336 5.78 6.002 6.224 6.668 6.89 7.334 7.778 8 8.389 8.611 9.055 9.499 9.777 10.221 10.665 10.887 11.109 11.553 11.775 12.219 12.663 12.885 13.107 13.329 13.773 14.051 14.273 14.495 14.939 15.328 15.55 15.994 16.438 16.66 17.104 17.548 17.937 18.159 18.603 19.047 19.325 19.769 20.158 20.38 20.769 21.213 21.657 21.879 22.323 22.767 22.989 23.433 23.877 24.155 24.599 24.877 25.099 25.543 25.765 26.209 26.653 26.875 27.264 27.708 28.375 28.597 29.041 29.485 29.874 30.096 30.318 30.596 30.874 31.318 31.762 32.206 32.428 32.872 33.08" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Glinidas (repaglinida y nateglinida): útiles en pacientes con un horario de comidas irregular.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 360.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9448 1.5008 1.9448 2.3338 2.7778 3.0558 3.3338 3.5558 3.8338 4.0306 4.4746 4.6714 4.8934 5.3374 5.7264 5.9232 6.3672 6.8112 7.2002 7.4222 7.8662 8.3102 8.5882 9.0322 9.4212 9.618 10.062 10.506 10.95 11.1468 11.5908 12.2578 12.4798 12.7578 13.2018 13.6458 13.8426 14.0646 14.5086 14.7054 15.1494 15.5934 15.9824 16.2044 16.5934 16.7902 17.1792 17.4012 17.598 17.987 18.431 18.6278 19.0168 19.4608 19.6828 19.9608 20.4048 20.8488 21.0456 21.4896 21.9336 22.3776 22.5744 22.9634 23.4074 24.0744 24.2964 24.7404 25.1844 25.4064 25.6032 25.9922 26.4362 26.633 27.077 27.521 27.965 28.1618 28.6058 28.8838 29.3278 29.7168 30.1608 30.5498 30.9938 31.1906 31.6346 32.0786 32.5226 32.7194 32.9414 33.1634 33.6074 34.0514 34.3294 34.7734 35.1624 35.3844 35.8284 36.2724 36.4692 36.7472 37.1912 37.6352 37.8572 38.3012 38.7452 38.942 39.331 39.5278 39.9168 40.3608 40.6388 40.9168 41.3608 41.5576 42.0016 42.4456 42.6424 42.8644 43.3084 43.6974 44.1414 44.3634 44.5854" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Advertir a los pacientes que omitan la dosis si se saltan una comida, ya que provoca una liberación rápida y corta de insulin</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 470.453396 360.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 0.8628 1.3068 1.7508 2.0288 2.2256 2.4476 2.8916 3.0884 3.5324 3.9764 4.4204" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">a, por lo que </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701005 349.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.61 1.832 2.276 2.498 2.942 3.386 3.775 4.219 4.663 5.052 5.496 5.94 6.384 6.828 7.272 7.55 7.772 8.216 8.66 9.104 9.326 9.77 9.992 10.436 10.88 11.324 11.546 11.99 12.379 12.823 13.49 13.712 14.156" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">podría desencadenar una hipoglucemia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.2368 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3292 0.5612 1.0152 1.4692 1.7012 2.1552 2.3872 2.8412 3.2952 3.5832 4.0372 4.4362 4.7544 5.2084 5.6624 5.9806 6.4346 6.6666 6.9546 7.4086 7.6966 8.1506 8.3826 8.8366 9.2356 9.6896 10.0886 10.3206 10.7746 11.2286 11.6276 12.0816 12.4806 12.7988 13.0308 13.4848 13.8838 14.3378 14.6258 15.0798 15.5338 15.9328 16.3868 16.705 17.104 17.4222 18.0992 18.3312 18.7852 19.0732 19.3052 19.5932 20.0472 20.2792 20.5112 20.7432 21.0614 21.4604 21.9144 22.2024 22.4904 22.9444 23.3434 23.7424 23.9744 24.4284 24.8824 25.2006 25.6546 26.1086 26.4268 26.8808 27.1128 27.5668 28.0208 28.3088 28.7628 28.9948 29.4488 29.8478 30.3018 30.9788 31.2108 31.6648 32.0638 32.382 32.836 33.29 33.689 33.977 34.431 34.719 35.173 35.627 36.081 36.313 36.767 36.999 37.453 37.852 38.1702 38.5692 39.0232 39.4772 39.7954 40.2494 40.4814 40.9354 41.3344 41.7884 42.4654 42.6974 43.1514 43.5504 43.8686 44.3226 44.7766 45.1756 45.6296 45.8616 46.3156 46.7146 47.0328 47.4868 47.9408 48.259" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Inhibidores de alfa-glucosidasas (acarbosa y migritol): corrección de hiperglucemias postprandiales con glucemias basales no m</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 502.6491 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.454 0.843" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">uy </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196894 316.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.454 0.686 1.14 1.539 1.993 2.447 2.901" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">elevadas</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196894 305.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.444 3.833 4.277 4.666 5.11 5.554 5.998 6.442 6.72 6.942 7.386 7.608 7.83 8.052 8.274 8.718 8.996 9.44 9.662 10.106 10.55 10.939 11.161 11.605" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efecto secundario: ﬂ atulencia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196894 294.8387) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.556 2 2.222 2.666 2.944 3.388 3.832 4.276 4.665 5.109 5.553 5.775 6.219 6.441 6.885 7.329 7.773 7.995 8.439 8.828 9.272 9.939 10.161 10.605 10.994 11.216 11.66 12.104 12.326 12.993 13.437 13.881 14.325 14.603 15.047 15.325 15.769 16.213 16.435 16.879" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- No producen hipoglucemias en monoterapia.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3387 0.8947 1.1167 1.3387 1.6167 2.0607 2.3937 2.8377 3.2817 3.7257 4.1147 4.3354 4.5574 5.0014 5.2234 5.6674 6.1114 6.3334 6.5554 6.8334 7.2774 7.6104 8.0544 8.4984 8.9424 9.1631 9.5521 9.7728 10.0508 10.4948 10.8838 11.1058 11.5498 11.7718 11.9938 12.2718 12.7158 13.0488 13.4928 13.9368 14.3808 14.6028 14.8248 15.0455 15.4345 15.8785 16.5455 16.9895 17.2115 17.6555 18.0995 18.4885 18.7105 19.1545 19.5985 19.8192 20.2632 20.7072 20.9279 21.3719 21.8159 22.2049 22.4269 22.8709 23.3149 23.5929 24.0369 24.4259 24.6466 25.0906 25.5346 25.9786 26.3676 26.8116 27.2006 27.4213 27.8653 28.3093 28.7533 29.1973 29.6413 29.862 30.14 30.418 30.862 31.251 31.695 32.084 32.528 32.7487 32.9707 33.4147 33.6354 34.3024 34.7464 35.1904 35.6344 35.9124 36.3564 36.6344 37.0784 37.5224 37.7444 38.1884 38.4091 38.7981 39.2421 39.6861 39.9068 40.2958 40.7398 40.9618 41.2398 41.6838 42.1278 42.3498 42.5718 43.0158 43.2938 43.7378 44.1818 44.5708 44.7915 45.1805 45.4012 46.0682" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Glitazonas (pioglitazona y rosiglitazona): combinación en pacientes obesos donde fracasa la monoterapia con sulfonilureas y me</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 480.743995 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.556 1 1.278 1.945 2.167 2.611 3.055" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">tformina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 261.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.444 3.833 4.277 4.666 5.11 5.554 5.998 6.442 6.72 6.942 7.386 7.608 7.83 8.274 8.552 8.996 9.44 9.884 10.273 10.717 11.161 11.383 11.661 12.105 12.383 12.827 13.271 13.66 13.882 14.326 14.77 14.992 15.436 15.88 16.102 16.324 16.546 16.99 17.434 17.656 18.1 18.544 18.933" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Efecto secundario: producen retención de líquidos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 239.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.222 1.722 1.944 2.166 2.666 3.166" font-family="g_d0_f6" font-size="1px" fill="rgb(64,198,192)">Insulina </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 217.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.721 2.165 2.609 3.053 3.275 3.719 4.163 4.385 4.829 5.051 5.495 5.939 6.383 6.661 7.105 7.494 7.716 7.994 8.216 8.66 9.104 9.326 9.77 9.992 10.381 10.603 11.047 11.491 11.713 11.991 12.213 12.657 13.101 13.323 13.767 13.989 14.378 14.822 15.266 15.488 15.932 16.376 16.765 17.154 17.598 18.265 18.709 19.153 19.597 19.986 20.43 20.819 21.041 21.485 21.929 22.373 22.762 22.984 23.428 23.872 24.316 24.76 25.204 25.593 25.815 26.259 26.481 26.925 27.147 27.591 28.035 28.479 28.757 29.201 29.59 29.812 30.479 30.923 31.145 31.367 31.756 32.2 32.644 32.922 33.2 33.644 33.866 34.31 34.754 35.198" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Indicada en diabetes tipo 1 y en tipo 2 con descompensaciones agudas o diabetes mal controlada.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 195.838499) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.167 1.611 2.055 2.444 2.666 2.944 3.166 3.555 3.999 4.388 4.61 5.054 5.498 5.72 6.164 6.608 7.275 7.497 7.941 8.163 8.552 8.83 9.108 9.552 9.941 10.163 10.607 11.051 11.273 11.717 12.161 12.383 12.605 13.049 13.271 13.493 13.937 14.326 14.77 14.992 15.214 15.658 16.102" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dispositivos de administración de la insulina:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.505 1.727 2.171 2.615 3.059 3.448 3.67 4.114 4.558 4.78 5.002 5.446 5.835 6.279 6.501 6.723 7.167 7.611 7.833 8.055 8.499 8.943 9.221 9.665 9.887 10.331 10.609 10.831 11.053 11.275 11.608 12.052 12.33 12.552 12.941 13.385 13.829 14.051 14.273 14.717 15.106 15.328 15.717 15.939 16.383 16.772 16.994 17.383 17.827 18.216 18.438 18.827 19.049 19.493 19.715 20.159 20.548 20.77 21.214 21.658 21.88 22.102 22.546 22.935 23.379 23.601 23.823 24.267 24.711 24.933 25.155 25.544 25.988 26.21 26.599 27.043 27.487 27.876 28.32 28.764 29.042 29.32 29.764 30.153 30.375 30.819 31.263 31.485 31.929 32.373 32.595 32.817 33.261 33.65 33.872 34.261 34.483 34.927 35.149 35.593 35.982 36.204 36.648 37.092 37.314 37.536 37.98 38.369 38.813 39.035 39.257 39.701 40.145 40.367 40.811 41.2 41.422 41.866 42.31 42.532 42.976 43.42 43.864" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Jeringas de insulina: para utilizar con los clásicos viales de insulina. La concentración de los viales de insulina es de 100 </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 458.904616 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.111 1.778 2" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">UI/ml.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 162.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 162.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.005 1.449 2.116 2.56 2.949 3.171 3.56 3.782 4.004 4.448 4.726 4.948 5.392 5.836 6.28 6.669 6.891 7.335 7.613 8.057 8.446 8.89 9.168 9.612 10.056 10.5 10.944 11.333" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Plumas y jeringas precargadas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.95 2.394 2.838 3.227 3.449 3.893 4.337 4.559 4.781 5.225 5.503 5.947 6.336 6.558 7.002 7.446 7.668 8.057 8.501 8.945 9.223 9.445 9.889 10.333 10.777 10.999 11.443 11.887 12.109 12.331 12.775 13.164 13.608 13.83 14.052 14.496 14.94 15.162 15.551 15.995 16.439 16.828 17.272 17.55 17.994 18.438 18.882 19.326" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Bombas de infusión continua de insulina subcutánea.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 129.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.5 1 1.5 2 2.5 3 3.278 3.778 4.278 4.5 5 5.278 5.778 6.278 6.778 7.056 7.556 7.834 8.334 8.834 9.112 9.612 10.112" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Educación diabetológica </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 107.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 107.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.95 1.172 1.561 2.005 2.227 2.454 2.898 3.342 3.731 3.953 4.342 4.786 5.008 5.235 5.624 6.068 6.512 6.79 7.068 7.512 7.734 8.178 8.567 8.794 9.238 9.682 9.909 10.353 10.575 11.019 11.408 11.852 12.519 12.741 13.185 13.412 13.801 14.028 14.472 14.694 15.138 15.527 15.971 16.36 16.804 17.082 17.304 17.748 17.97 18.197 18.475 18.919 19.308 19.752 19.974 20.363 20.807 21.034 21.478 21.922 22.149 22.371 22.815 23.204 23.648 24.037 24.426 24.648 25.092 25.536 25.763 26.207 26.651 26.878 27.1 27.544 27.933 28.377 28.599 28.821 29.265 29.709 29.931 30.158 30.436 30.88 31.269 31.713 32.157 32.601 32.99 33.212 33.879 34.101 34.545 34.989 35.267 35.711 35.938 36.382 36.826 37.053 37.275 37.719 38.108 38.335 38.724 38.946 39.39 39.668 40.112 40.779 41.223 41.612 41.839 42.283 42.727 42.954 43.176 43.62 44.009 44.236 44.625 45.069 45.736" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Nivel básico: controles de glucemia y glucosuria, técnica de inyección de insulina, reconocimiento de los síntomas de las comp</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 477.755988 107.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.444 0.833 1.277 1.666 1.888 2.332 2.776 3.22 3.609" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">licaciones </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 96.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.776 2.22 2.609 2.831 3.053 3.497 3.941 4.219 4.886 5.33 5.719 5.941 6.385 6.607 7.051 7.329 7.773 8.051 8.273 8.662 9.106 9.495 9.717 9.939 10.383 10.605 11.049 11.327 11.716 11.938 12.327 12.549 12.993 13.215 13.604 13.826 14.215 14.659 14.881 15.325 15.769 16.213 16.657 16.879 17.323 17.767 17.989 18.211 18.655 19.044 19.266 19.71 19.932 20.376 20.765" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">agudas, normas dietéticas, ejercicio y cuidado de los pies.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3387 0.9497 1.1717 1.5607 2.0047 2.2267 2.4384 2.8824 3.2714 3.7154 4.1594 4.4924 4.9364 5.3804 5.8244 6.0464 6.2581 6.7021 7.1461 7.4241 7.8681 8.2571 8.7011 9.1451 9.4231 9.7011 10.1451 10.3671 10.5891 10.8008 11.2448 11.5228 11.9668 12.3558 12.7998 13.2438 13.6328 13.8548 14.2988 14.7428 14.9545 15.3435 15.5552 15.8332 16.1112 16.5552 16.8332 17.2772 17.9442 18.1662 18.6102 19.0542 19.3322 19.7762 19.9879 20.4319 20.8759 21.0876 21.3096 21.7536 22.1426 22.3543 22.7433 23.1873 23.8543 24.2983 24.5203 24.7423 25.1313 25.5753 25.9643 26.1863 26.6303 27.0743 27.5183 27.9073 28.119 28.563 29.007 29.451 29.895 30.339 30.728 30.95 31.1617 31.6057 32.0497 32.4937 32.9377 33.2157 33.6597 34.0487 34.2707 34.7147 35.1587 35.3704 35.8144 36.0261 36.2481 36.6921 36.9038 37.2928 37.5148 37.9588 38.4028 38.6145 39.0035 39.4475 39.8365 40.0585 40.5025 40.7245 40.9362 41.3252 41.5369 41.7589 42.2029 42.6469 43.0909 43.3689 43.8129 44.0349 44.2569 44.4686 44.7466 45.0246" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Nivel avanzado: autocontrol, prevención y tratamiento de las complicaciones agudas, adaptación a la vida social y laboral, tra</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 471.350684 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.389 1.611 2.055 2.499 2.777 3.221 3.4327 3.8767 4.3207" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">tamiento de </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 74.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.277 1.666 1.888 2.166 2.61 3.054 3.443 3.665 4.109 4.553 4.997 5.386 5.608 6.052 6.441 6.885 7.329 7.718 7.94 8.384 8.606 9.05 9.439" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">las situaciones especiales.</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>